This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
A Mid-South family is taking part in a huge victory this week for children with a rare disease.
Monday, the FDA approved the first drug to treat Duchenne Muscular Dystrophy going against the recommendations of its own doctors.
It’s a move Dalton Al-Chokachi and his mother, Stacie, have fought to make happen, even testifying on Capitol Hill.
